Published in Lab Law Weekly, July 6th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Isotechnika.
Report 1: Isotechnika today announced that the Company has been selected to give an oral presentation during the American Transplant Congress in San Francisco, California.
An overview of the latest Phase 2b kidney transplant trial (PROMISE) results will be presented during an oral presentation by Dr. Stephen Busque, one of the principal investigators involved in the PROMISE trial. Dr. Busque's oral presentation is scheduled to take place on Sunday, May 6 at 5:20 p.m....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.